U S Global Investors Inc Exelixis, Inc. Transaction History

U S Global Investors Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$20.67 - $26.94 $843,625 - $1.1 Million	-40,814 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$14.46 - $21.8 $450,255 - $678,808	-31,138 Reduced 43.28%	40,814 $703,000
Q4 2019 Feb 12, 2020	BUY	$15.15 - $18.89 $204,100 - $254,486	13,472 Added 23.04%	71,952 $1.27 Million
Q3 2019 Nov 12, 2019	BUY	$17.68 - $22.65 $90,539 - $115,990	5,121 Added 9.6%	58,480 $1.03 Million
Q2 2019 Aug 09, 2019	BUY	$18.93 - $24.75 $587,719 - $768,413	31,047 Added 139.15%	53,359 $1.14 Million
Q1 2019 May 13, 2019	BUY	$19.6 - $24.76 $437,315 - $552,445	22,312 New	22,312 $531,000

502

243M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.9B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of U S Global Investors Inc, based on Form 13F filings with the SEC.

Stay updated on U S Global Investors Inc with notifications on news.